Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry-Reference-Cited by-同舟云学术

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

Published:2016-04-18 Issue:12 Volume:57 Page:2777-2783
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Mocikova Heidi,Pytlik Robert,Sykorova Alice,Janikova Andrea,Prochazka Vit,Vokurka Samuel,Berkova Adela,Belada David,Campr Vit,Buresova Lucie,Trneny Marek,

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2016.1167203

Reference29 articles.

1. Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma: Radiation Therapy Oncology Group Study 93-10

2. Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

3. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

4. High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study

5. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis;Clinical Lymphoma Myeloma and Leukemia;2023-10

2. Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis;Blood Advances;2023-09-15

3. High-dose methotrexate, thiotepa, orelabrutinib combined with or without rituximab in primary or secondary central nervous system diffuse large B-cell lymphoma: a single-center retrospective analysis;Journal of Cancer;2023

4. The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma;Cancers;2021-04-16

5. Oncological Mimics in Inflammatory CNS Disease;Neuroimmunology;2021